BioAdaptives, Inc. announced the signing of a non-exclusive license agreement with LY Research Corporation to market a patented product for glucose management. It contains several biologically active compounds called bitters, including charantin and momordicin that help to maintain glucose health. It helps to inhibit the conversion of sugar into fat and stimulates the breakdown of fat in the body.

In the United States, approximately 84 million adults--more than 1 out of 3--have prediabetes. Of those with prediabetes, 90% don't know they have it.